Physician

Meera Gopal Iyengar, MD

According to 2025 Medicare claims, Meera Iyengar, MD (NPI: 1548429681) practices hematology/oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34711-1977.

Iyengar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 891 traditional Medicare patients, billed 269,508 HCPCS/CPT codes, and received $3,998,282 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,265 prescription claims across 277 beneficiaries totaling $3,276,432 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 34 claims. Open Payments data shows 44 records totaling $954. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $960,773 to $3,998,282. Similarly, Part D prescription costs have risen steadily, from $85,210 to $3,276,432. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $960,773 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,570,166 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,014,363 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,134,868 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,037,430 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,492,389 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,419,171 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,622,867 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,483,127 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,998,282 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201573377,569$960,773
2016785155,641$1,570,166
2017793228,519$3,014,363
2018955279,109$3,134,868
20191,023281,564$3,037,430
2020836265,025$3,492,389
2021765211,479$3,419,171
2022949293,609$3,622,867
2023941288,090$3,483,127
2024891269,508$3,998,282

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.4M2015 Drug cost: $85,210 (USD; Tot_Drug_Cst)2016 Drug cost: $487,612 (USD; Tot_Drug_Cst)2017 Drug cost: $736,633 (USD; Tot_Drug_Cst)2018 Drug cost: $1,472,776 (USD; Tot_Drug_Cst)2019 Drug cost: $2,220,108 (USD; Tot_Drug_Cst)2020 Drug cost: $3,125,465 (USD; Tot_Drug_Cst)2021 Drug cost: $2,942,798 (USD; Tot_Drug_Cst)2022 Drug cost: $4,436,279 (USD; Tot_Drug_Cst)2023 Drug cost: $4,248,632 (USD; Tot_Drug_Cst)2024 Drug cost: $3,276,432 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576236$85,210
201694380$487,612
2017121604$736,633
2018149718$1,472,776
2019168895$2,220,108
20201821,100$3,125,465
20212021,121$2,942,798
20222911,460$4,436,279
20232951,422$4,248,632
20242771,265$3,276,432

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.9K$5.7K2017 Medicare payment: $500 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $750 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $377 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,722 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R12$500
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R23$750
2022N/R12$377
2023N/R34$5,722
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5931,235$66
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's246295$13
96372Injection of drug or substance under skin or into muscle2641,197$10
36415Insertion of needle into vein for collection of blood sample7112,335$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6672,331$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide541,414$1,002,743
JakafiRuxolitinib Phosphate30900$495,849
PomalystPomalidomide24616$455,997
ImbruvicaIbrutinib15420$244,875
NinlaroIxazomib Citrate14392$182,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$954Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Meera Gopal Iyengar, MD?

Tedicare shows public-source Medicare data for Meera Gopal Iyengar, MD (NPI 1548429681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Meera Gopal Iyengar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Meera Gopal Iyengar, MD?

Meera Gopal Iyengar, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Meera Gopal Iyengar, MD have Open Payments data?

Meera Gopal Iyengar, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.